Output Explorer

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Privileged and Confidential:
Attorney - Client Communication and
Attorney Work Product
* * * ** * * * * * * * * * * * * * * * * * * * *
3.
Documents relating to preclinical studies, clinical trials, epidemiological studies
or other studies involving ACTOS or ACTOS@ combination medicines, and
PPAR Agonists;
4.
Scientific and Medical Affairs documents relating to ACTOS@ or ACTOS@
combination medicines and PPAR Agonists;
5.
Pharmacovigilance (safety surveillance) documents relating to ACTOS@ or
ACTOS@ combination medicines, and PPAR Agonists;
6.
Regulatory documents relating to ACTOS@ or ACTOS@ combination
medicines, and PPAR Agonists;
7.
Documents relating to the labeling of ACTOS@ or ACTOS@ combination
medicines, and PPAR Agonists;
8.
Documents relating to communications, contacts, or interactions with Patients,
Physicians, Hospitals, Clinics, other Healthcare Professionals, Third Party
Payors, or government entities in the United States regarding ACTOS@ or
ACTOS@ combination medicines, and PPAR Agonists (if any);
9.
Documents relating to samples of ACTOS@ or ACTOS@ combination
medicines, and PPAR Agonists (if any), provided to Physicians or other
Healthcare Professionals in the United States;
10. Documents relating to marketing and promotion of ACTOS@ or ACTOS@
combination medicines and, and PPAR Agonists (if any) in the United States,
including marketing/promotional materials, direct-to-consumer advertising, sales
aids, visuals, sales scripts, sales guides, reminder pieces, sales training materials,
IMS data, marketing plans, market analysis, and agreements with any person or
firm hired to assist with marketing); and,
11. Documents relating to advisory boards and key opinion leaders in the United
States regarding ACTOS@ or ACTOS@ combination medicines, and PPAR
Agonists (if any).
For purposes of identifying documents to be preserved, the terms "relating to" or "regarding"
should be understood as broadly as possible and any doubts concerning particular documents
should be resolved in favor of preservation. Appropriate preservation of documents in
accordance with this Notice is of the highest priority for you and the Company.
For purposes of this Notice, the term "documents" should be understood to have the broadest
possible meaning. It includes, but is not limited to, paper and electronically stored information:
paper documents, includes without limitation, correspondence; faxes; memoranda;
notes; desk files, working files, or other personal files; presentations; calendars;
contracts or other agreements; financial statements and related materials; message
slips; phone logs; reports; statements; manuals; advertisements and other marketing
materials; and,
electronically stored information, includes without limitation e-mails and attachments;
electronic calendars, task lists, journals, and notes; user files such as Microsoft Word,
Excel, or PowerPoint files or Adobe PDF files; video recordings; instant messages;
3
Confidential - Subject to Protective Order
TAK-RIM30b6-00000827
Source: https://www.indup534500095ts.ucsf.edu/docs/srjf0226

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.